메뉴 건너뛰기




Volumn 120, Issue 6, 2012, Pages 1197-1201

A prognostic model to predict survival in 867 World Health Organization - Defined essential thrombocythemia at diagnosis: A study by the International Working Group on Myelofibrosis Research and Treatment

(29)  Passamonti, Francesco a   Thiele, Jürgen b   Girodon, Francois c   Rumi, Elisa d   Carobbio, Alessandra e   Gisslinger, Heinz f   Kvasnicka, Hans Michael g   Ruggeri, Marco h   Randi, Maria Luigia i   Gangat, Naseema j   Vannucchi, Alessandro Maria k   Gianatti, Andrea e   Gisslinger, Bettina f   Müllauer, Leonhard f   Rodeghiero, Francesco h   D'Amore, Emanuele S G h   Bertozzi, Irene i   Hanson, Curtis A j   Boveri, Emanuela d   Marino, Filippo i   more..


Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTERNATIONAL PROGNOSTIC SCORE FOR ESSENTIAL THROMBOCYTHEMIA MODEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHENOTYPE; POLYCYTHEMIA VERA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENESCENCE; SURVIVAL; THROMBOCYTHEMIA; THROMBOSIS; WORLD HEALTH ORGANIZATION;

EID: 84865187605     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-403279     Document Type: Article
Times cited : (215)

References (27)
  • 3
    • 32144461605 scopus 로고    scopus 로고
    • Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors
    • Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006;81(2):159-166. (Pubitemid 43205767)
    • (2006) Mayo Clinic Proceedings , vol.81 , Issue.2 , pp. 159-166
    • Wolanskyj, A.P.1    Schwager, S.M.2    McClure, R.F.3    Larson, D.R.4    Tefferi, A.5
  • 5
    • 38049188368 scopus 로고    scopus 로고
    • Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes
    • Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood. 2008;111(1):60-70.
    • (2008) Blood , vol.111 , Issue.1 , pp. 60-70
    • Wilkins, B.S.1    Erber, W.N.2    Bareford, D.3
  • 6
    • 79957611312 scopus 로고    scopus 로고
    • Essential thrombocythemia versus early primary myelofibrosis: A multicenter study to validate the WHO classification
    • Thiele J, Kvasnicka HM, Mullauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710-5718.
    • (2011) Blood , vol.117 , Issue.21 , pp. 5710-5718
    • Thiele, J.1    Kvasnicka, H.M.2    Mullauer, L.3    Buxhofer-Ausch, V.4    Gisslinger, B.5    Gisslinger, H.6
  • 7
    • 80051803115 scopus 로고    scopus 로고
    • Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international study
    • Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol. 2011;29(23):3179-3184.
    • (2011) J Clin Oncol , vol.29 , Issue.23 , pp. 3179-3184
    • Barbui, T.1    Thiele, J.2    Passamonti, F.3
  • 8
    • 43949103121 scopus 로고    scopus 로고
    • Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
    • DOI 10.1038/leu.2008.72, PII LEU200872
    • Cervantes F, Passamonti F, Barosi G. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia. 2008;22(5):905-914. (Pubitemid 351698623)
    • (2008) Leukemia , vol.22 , Issue.5 , pp. 905-914
    • Cervantes, F.1    Passamonti, F.2    Barosi, G.3
  • 9
    • 79551491928 scopus 로고    scopus 로고
    • Philadelphia-negative classical myeloproliferative neoplasms: Critical concepts and management recommendations from European LeukemiaNet
    • Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761-770.
    • (2011) J Clin Oncol , vol.29 , Issue.6 , pp. 761-770
    • Barbui, T.1    Barosi, G.2    Birgegard, G.3
  • 10
    • 79960238893 scopus 로고    scopus 로고
    • Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study
    • Palandri F, Polverelli N, Catani L, Ottaviani E, Baccarani M, Vianelli N. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study. Ann Hematol. 2011;90(8):933-938.
    • (2011) Ann Hematol , vol.90 , Issue.8 , pp. 933-938
    • Palandri, F.1    Polverelli, N.2    Catani, L.3    Ottaviani, E.4    Baccarani, M.5    Vianelli, N.6
  • 11
    • 77950945887 scopus 로고    scopus 로고
    • Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: A population-based study of 311 patients
    • Girodon F, Dutrillaux F, Broseus J, et al. Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients. Leukemia. 2010;24(4):900-903.
    • (2010) Leukemia , vol.24 , Issue.4 , pp. 900-903
    • Girodon, F.1    Dutrillaux, F.2    Broseus, J.3
  • 12
    • 33846540216 scopus 로고    scopus 로고
    • Risk stratification for survival and leukemic transformation in essential thrombocythemia: A single institutional study of 605 patients
    • DOI 10.1038/sj.leu.2404500, PII 2404500
    • Gangat N, Wolanskyj AP, McClure RF, et al. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia. 2007;21(2):270-276. (Pubitemid 46158119)
    • (2007) Leukemia , vol.21 , Issue.2 , pp. 270-276
    • Gangat, N.1    Wolanskyj, A.P.2    McClure, R.F.3    Li, C.-Y.4    Schwager, S.5    Wu, W.6    Tefferi, A.7
  • 15
    • 79957975519 scopus 로고    scopus 로고
    • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients
    • Carobbio A, Thiele J, Passamonti F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011;117(22):5857-5859.
    • (2011) Blood , vol.117 , Issue.22 , pp. 5857-5859
    • Carobbio, A.1    Thiele, J.2    Passamonti, F.3
  • 16
    • 66749172267 scopus 로고    scopus 로고
    • Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: A population-based study
    • Girodon F, Bonicelli G, Schaeffer C, et al. Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 2009;94(6):865-869.
    • (2009) Haematologica , vol.94 , Issue.6 , pp. 865-869
    • Girodon, F.1    Bonicelli, G.2    Schaeffer, C.3
  • 17
    • 33947262701 scopus 로고    scopus 로고
    • Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: Interaction with treatment, standard risk factors, and Jak2 mutation status
    • DOI 10.1182/blood-2006-09-046342
    • Carobbio A, Finazzi G, Guerini V, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood. 2007;109(6):2310-2313. (Pubitemid 46425868)
    • (2007) Blood , vol.109 , Issue.6 , pp. 2310-2313
    • Carobbio, A.1    Finazzi, G.2    Guerini, V.3    Spinelli, O.4    Delaini, F.5    Marchioli, R.6    Borrelli, G.7    Rambaldi, A.8    Barbui, T.9
  • 18
    • 54049086618 scopus 로고    scopus 로고
    • Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
    • Carobbio A, Finazzi G, Antonioli E, et al. Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia. Blood. 2008;112(8):3135-3137.
    • (2008) Blood , vol.112 , Issue.8 , pp. 3135-3137
    • Carobbio, A.1    Finazzi, G.2    Antonioli, E.3
  • 19
    • 45749098579 scopus 로고    scopus 로고
    • Leukocytosis and risk stratification assessment in essential thrombocythemia
    • Carobbio A, Antonioli E, Guglielmelli P, et al. Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol. 2008;26(16):2732-2736.
    • (2008) J Clin Oncol , vol.26 , Issue.16 , pp. 2732-2736
    • Carobbio, A.1    Antonioli, E.2    Guglielmelli, P.3
  • 20
    • 69249223035 scopus 로고    scopus 로고
    • Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms
    • Caramazza D, Caracciolo C, Barone R, et al. Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol. 2009;88(10):967-971.
    • (2009) Ann Hematol , vol.88 , Issue.10 , pp. 967-971
    • Caramazza, D.1    Caracciolo, C.2    Barone, R.3
  • 21
    • 55549099571 scopus 로고    scopus 로고
    • Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients
    • Passamonti F, Rumi E, Arcaini L, et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 2008;93(11):1645-1651.
    • (2008) Haematologica , vol.93 , Issue.11 , pp. 1645-1651
    • Passamonti, F.1    Rumi, E.2    Arcaini, L.3
  • 22
    • 73149090129 scopus 로고    scopus 로고
    • Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera
    • Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer. 2009;115(24):5740-5745.
    • (2009) Cancer , vol.115 , Issue.24 , pp. 5740-5745
    • Gangat, N.1    Wolanskyj, A.P.2    Schwager, S.M.3    Hanson, C.A.4    Tefferi, A.5
  • 23
    • 69249217916 scopus 로고    scopus 로고
    • Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia
    • Passamonti F, Rumi E, Pascutto C, Cazzola M, Lazzarino M. Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. J Thromb Haemost. 2009;7(9):1587-1589.
    • (2009) J Thromb Haemost , vol.7 , Issue.9 , pp. 1587-1589
    • Passamonti, F.1    Rumi, E.2    Pascutto, C.3    Cazzola, M.4    Lazzarino, M.5
  • 24
    • 55049131023 scopus 로고    scopus 로고
    • Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia
    • Dahabreh IJ, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M. Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res. 2009;33(1):67-73.
    • (2009) Leuk Res , vol.33 , Issue.1 , pp. 67-73
    • Dahabreh, I.J.1    Zoi, K.2    Giannouli, S.3    Zoi, C.4    Loukopoulos, D.5    Voulgarelis, M.6
  • 25
    • 68549116852 scopus 로고    scopus 로고
    • Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
    • Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Buller HR, Cattaneo M. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res. 2009;124(4):409-417.
    • (2009) Thromb Res , vol.124 , Issue.4 , pp. 409-417
    • Lussana, F.1    Caberlon, S.2    Pagani, C.3    Kamphuisen, P.W.4    Buller, H.R.5    Cattaneo, M.6
  • 26
    • 80555154949 scopus 로고    scopus 로고
    • Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
    • Passamonti F, Maffioli M, Caramazza D, Cazzola M. Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies. Oncotarget. 2011;2(6):485-490.
    • (2011) Oncotarget , vol.2 , Issue.6 , pp. 485-490
    • Passamonti, F.1    Maffioli, M.2    Caramazza, D.3    Cazzola, M.4
  • 27
    • 78651344350 scopus 로고    scopus 로고
    • Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: A single center study of 433 patients
    • Caramazza D, Begna KH, Gangat N, et al. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia. 2011;25(1):82-88.
    • (2011) Leukemia , vol.25 , Issue.1 , pp. 82-88
    • Caramazza, D.1    Begna, K.H.2    Gangat, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.